The remote access software nanoConnectX brings all the functions and display options of the touchscreen to the systems users’ computers so that they can start, monitor, and control print jobs of connected printers from anywhere. This reduces preparation time in the lab to a minimum and significantly simplifies group collaboration when sharing a system.
“The launch of the Quantum X shape demonstrates the innovative potential of high-precision 3D printing for many application areas, especially for demanding life science applications,” says Erik Gatenholm, CEO and Co-Founder of BICO. “Nanoscribe is setting new standards in 3D Microfabrication to discover tomorrow’s technologies, and I couldn’t be prouder to have them as a part of our team at BICO.”
To learn more about the Quantum X shape, please visit the product website.
The medium-sized company develops and produces 3D printers and maskless lithography systems for microfabrication as well as specially developed printing materials and application-specific solution sets. The specialist for additive manufacturing of high-precision structures and objects on the nano-, micro- and mesoscale was founded in 2007 as a spin-off of the Karlsruhe Institute of Technology (KIT) and has been part of the BICO Group (formerly CELLINK Group) since June 2021. More than 3,000 users and operators at top universities and innovative industrial companies worldwide benefit from the groundbreaking technology and application tailored solutions for 3D Microfabrication. Nanoscribe has created its strong market leading position through high quality engineering and agility to continuously develop its products to meet customers’ high expectations.
Founded in 2016, BICO (formerly CELLINK) is the leading bio convergence company in the world by combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people's health and lives for the better.
With a focus on the application areas of bioprinting, multiomics, cell line development, and diagnostics, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. We create the future of health.
The Group’s products are trusted by more than 2,000 laboratories, including all the top 20 pharmaceutical companies, are being used in more than 65 countries, and have been cited in more than 1,850 publications. BICO is listed on the Nasdaq the Stockholm under BICO. www.bico.com
Img. 1: Quantum X shape is Nanoscribe’s new high-precision 3D printer featuring design freedom for virtually any 2.5D or 3D shaped structure and offering high-quality structures with maximum throughput.
Img. 2: Rapid and high-precision small series production of mechanical components. With Quantum X shape it is possible to print 200 typical structures overnight.
Img. 3: 3D-printed microneedles demonstrating the capabilities of Nanoscribe’s microfabrication technology to realize applications with high aspect ratios, shape accuracy and sharp tips with design variations at ease.
Img. 4: The nanoConnectX remote access software enables to start, monitor, and control print jobs remotely from any computer connected to the Quantum X shape system.
Right of use and media relations
Our image may be used free of charge for editorial purposes. Please state the source as follows: "Image: Nanoscribe, www.nanoscribe.com". The image must not be used for commercial purposes or passed on to third parties.
In case of questions or if you would like to be added to our press mailing list, please do not hesitate to contact Dr. Alena Kirchenbauer, firstname.lastname@example.org.
Stay up to date with our latest press releases about Nanoscribe and the world of 3D Microfabrication. Directly get in touch with us to discuss further press activities: Media relations